Exact Mass: 412.2828

Exact Mass Matches: 412.2828

Found 49 metabolites which its exact mass value is equals to given mass value 412.2828, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid

C23H40O6 (412.2825)


MG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)

1,3-Dihydroxypropan-2-yl (8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoic acid

C23H40O6 (412.2825)


MG(0:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(2:0/18:1(12Z)-O(9S,10R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C23H40O6 (412.2825)


DG(2:0/18:1(12Z)-O(9S,10R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(12Z)-O(9S,10R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-O(9S,10R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C23H40O6 (412.2825)


DG(18:1(12Z)-O(9S,10R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-O(9S,10R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:1(12Z)-O(9S,10R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C23H40O6 (412.2825)


DG(2:0/0:0/18:1(12Z)-O(9S,10R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-O(9S,10R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl 8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoic acid

C23H40O6 (412.2825)


DG(18:1(12Z)-O(9S,10R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/18:1(9Z)-O(12,13)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid

C23H40O6 (412.2825)


DG(2:0/18:1(9Z)-O(12,13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:1(9Z)-O(12,13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(9Z)-O(12,13)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid

C23H40O6 (412.2825)


DG(18:1(9Z)-O(12,13)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(9Z)-O(12,13)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:1(9Z)-O(12,13))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid

C23H40O6 (412.2825)


DG(2:0/0:0/18:1(9Z)-O(12,13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(9Z)-O(12,13)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid

C23H40O6 (412.2825)


DG(18:1(9Z)-O(12,13)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

palmonine C

palmonine C

C23H40O6 (412.2825)


   

8beta,18-dihydroxy-15-malonyloxy-ent-labdane

8beta,18-dihydroxy-15-malonyloxy-ent-labdane

C23H40O6 (412.2825)


   

Acetyl-leucyl-valyl-argininal

Acetyl-leucyl-valyl-argininal

C19H36N6O4 (412.2798)


   

Corymbosin|Corymbositin

Corymbosin|Corymbositin

C23H40O6 (412.2825)


   

3-methoxy Limaprost

3-methoxy-11,15S-dihydroxy-17S,20-dimethyl-9-oxo-prosta-13E-en-1-oic acid

C23H40O6 (412.2825)


   

Leupeptin analogue LVR (or VLR)

Leupeptin analogue LVR (or VLR)

C19H36N6O4 (412.2798)


   

(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

NCGC00380316-01!(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

C23H40O6 (412.2825)


   

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate

NCGC00381153-01![4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate

C23H40O6 (412.2825)


   

(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based: Match]

NCGC00380316-01!(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid [IIN-based: Match]

C23H40O6 (412.2825)


   

(5Z,7E)-(1S,3R)-1-fluoro-9,10-seco-5,7,10(19),16-cholestatetraen-23-yne-3,25-diol

1α-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrovitamin D3 / 1α-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrocholecalciferol

C27H37FO2 (412.2777)


   

1alpha-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrovitamin D3

(5Z,7E)-(1S,3R)-1-fluoro-9,10-seco-5,7,10(19),16-cholestatetraen-23-yne-3,25-diol

C27H37O2F (412.2777)


   

butyl prop-2-enoate,ethenyl acetate,ethenyl 8-methylnonanoate

butyl prop-2-enoate,ethenyl acetate,ethenyl 8-methylnonanoate

C23H40O6 (412.2825)


   

3-Methoxylimaprost

3-Methoxylimaprost

C23H40O6 (412.2825)


   

1alpha-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrovitamin D3/1alpha-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrocholecalciferol

1alpha-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrovitamin D3/1alpha-fluoro-25-hydroxy-16,17,23,23,24,24-hexadehydrocholecalciferol

C27H37FO2 (412.2777)


   

MG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/0:0)

MG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/0:0)

C23H40O6 (412.2825)


   

MG(0:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)

MG(0:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)

C23H40O6 (412.2825)


   

DG(2:0/18:1(12Z)-O(9S,10R)/0:0)

DG(2:0/18:1(12Z)-O(9S,10R)/0:0)

C23H40O6 (412.2825)


   

DG(18:1(12Z)-O(9S,10R)/2:0/0:0)

DG(18:1(12Z)-O(9S,10R)/2:0/0:0)

C23H40O6 (412.2825)


   

DG(2:0/0:0/18:1(12Z)-O(9S,10R))

DG(2:0/0:0/18:1(12Z)-O(9S,10R))

C23H40O6 (412.2825)


   

DG(18:1(12Z)-O(9S,10R)/0:0/2:0)

DG(18:1(12Z)-O(9S,10R)/0:0/2:0)

C23H40O6 (412.2825)


   

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C23H40O6 (412.2825)


   

[(2S)-2-acetyloxy-3-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2S)-2-acetyloxy-3-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C23H40O6 (412.2825)


   

[(2R)-3-acetyloxy-2-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2R)-3-acetyloxy-2-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C23H40O6 (412.2825)


   

[(2S)-3-acetyloxy-2-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[(2S)-3-acetyloxy-2-hydroxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C23H40O6 (412.2825)


   

N-(9Z-octadecenoyl)-L-methionine

N-(9Z-octadecenoyl)-L-methionine

C23H42NO3S- (412.2885)


   

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate

[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] octanoate

C23H40O6 (412.2825)


   

(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

(2Z)-2-[(E)-11-hydroxy-6-(hydroxymethyl)-2,4,8,10-tetramethyldodec-2-enylidene]-4-methylpentanedioic acid

C23H40O6 (412.2825)


   

2-[Hydroxy-(2-hydroxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C19H43NO6P+ (412.2828)


   

TG(20:1)

TG(4:0_6:0_10:1)

C23H40O6 (412.2825)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

3-({5-[2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpentyl}oxy)-3-oxopropanoic acid

3-({5-[2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpentyl}oxy)-3-oxopropanoic acid

C23H40O6 (412.2825)


   

3-{[(3s)-5-[(1s,2s,4as,5s,8ar)-2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpentyl]oxy}-3-oxopropanoic acid

3-{[(3s)-5-[(1s,2s,4as,5s,8ar)-2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpentyl]oxy}-3-oxopropanoic acid

C23H40O6 (412.2825)


   

(1r,2r)-1-[(1r,4s,5r,9s,10s,13r,14r,15r)-14-hydroxy-5,15-bis(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]propane-1,2,3-triol

(1r,2r)-1-[(1r,4s,5r,9s,10s,13r,14r,15r)-14-hydroxy-5,15-bis(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]propane-1,2,3-triol

C23H40O6 (412.2825)


   

1-[14-hydroxy-5,15-bis(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]propane-1,2,3-triol

1-[14-hydroxy-5,15-bis(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-14-yl]propane-1,2,3-triol

C23H40O6 (412.2825)


   

3,13-dihydroxy-6-isopropyl-12-methoxy-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl acetate

3,13-dihydroxy-6-isopropyl-12-methoxy-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl acetate

C23H40O6 (412.2825)


   

(2s)-n-[(1s)-1-{[(2s)-5-carbamimidamido-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-2-[(1-hydroxyethylidene)amino]-4-methylpentanimidic acid

(2s)-n-[(1s)-1-{[(2s)-5-carbamimidamido-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-2-[(1-hydroxyethylidene)amino]-4-methylpentanimidic acid

C19H36N6O4 (412.2798)


   

(1r,2s,3r,6r,7r,8r,9r,12s,13s)-3,13-dihydroxy-6-isopropyl-12-methoxy-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl acetate

(1r,2s,3r,6r,7r,8r,9r,12s,13s)-3,13-dihydroxy-6-isopropyl-12-methoxy-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl acetate

C23H40O6 (412.2825)


   

n-{1-[(5-carbamimidamido-1-oxopentan-2-yl)-c-hydroxycarbonimidoyl]-2-methylpropyl}-2-[(1-hydroxyethylidene)amino]-4-methylpentanimidic acid

n-{1-[(5-carbamimidamido-1-oxopentan-2-yl)-c-hydroxycarbonimidoyl]-2-methylpropyl}-2-[(1-hydroxyethylidene)amino]-4-methylpentanimidic acid

C19H36N6O4 (412.2798)